Want to see MDLN full AI Analyst Report?
Medline (MDLN) Stock Price & Analysis
MDLN Stock Chart & Stats
- Day’s Range
- $37.06 - $40.80
- 52-Week Range
- $31.37 - $50.88
- Previous Close
- $34.09
- Volume
- N/A
- Average Volume (3M)
- 9.78M
- Market Cap
- $44.82B
- Enterprise Value
- $62.30B
- Total Cash (Recent Filing)
- $3.61B
- Total Debt (Recent Filing)
- $29.00M
- Price to Earnings (P/E)
- 59.3
- Beta
- 0.98
- Next Earnings
- Mar 03, 2027 (Est.)
- EPS Estimate
- 0.4
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Organic Revenue Growth
The raised organic-sales outlook indicates sustained commercial momentum rather than reliance on temporary currency effects. High-single-digit growth expected into 2027, supported by same-store sales and implementations, provides a durable foundation for continued scale and customer expansion.
Cash Generation And Deleveraging
Strong free cash flow gives Medline internal funding for distribution, automation, product development, and debt reduction. The lower net-leverage level improves financial flexibility and supports resilience, although continued investment means capital allocation discipline remains important.
Customer And Network Expansion
Expansion of customer implementations increases the addressable base for Medline Brand conversion, which management says can create customer savings and margin-dollar growth. New automated distribution capacity should also improve throughput and responsiveness as the network scales.
Bears Say
Elevated Leverage
Leverage near or above equity reduces financial flexibility if operating conditions weaken, while declining equity increases the sensitivity of the capital structure. Debt obligations can compete with investments, acquisitions, or shareholder returns when cash demands rise.
Margin Conversion Pressure
The expected gap between sales and EBITDA growth shows that revenue expansion is not currently translating proportionally into operating profit. Inflation, capacity investments, automation, and quality spending could therefore constrain margin improvement over the next several quarters.
Bed Product Exit And Safety Action
The market exit removes an existing product line and creates remediation, replacement, refund, and reputational obligations. The reported safety issues and possible customer credits add execution uncertainty, with costs potentially extending across 2026 and 2027.
Medline News
MDLN FAQ
What was Medline’s price range in the past 12 months?
What is Medline’s market cap?
When is Medline’s upcoming earnings report date?
How were Medline’s earnings last quarter?
Is Medline overvalued?
Does Medline pay dividends?
What is Medline’s EPS estimate?
How many shares outstanding does Medline have?
What happened to Medline’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Medline?
What is the TipRanks Smart Score and how is it calculated?
Medline Stock Smart Score
Company Description
Medline
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.
- Sector
- General
- Industry
- Medical - Instruments & Supplies
- CEO
- James Boyle
- Employees
- 45,000
- Website
- www.medline.com
- Address
- 3 Lakes Drive, Northfield, IL, 60093, US
Medline (MDLN) Earnings & Revenues
MDLN Company Deck
MDLN Earnings Call
Earnings Call SentimentPositive
The call was broadly positive, supported by 10% third-quarter sales growth, 12% adjusted EBITDA growth, strong cash generation, improved leverage, raised 2026 organic sales guidance, customer-signing momentum, and continued strategic investment. The main concerns were near-term margin pressure, lower Supply Chain Solutions margins, elevated inflation and freight costs, the financial impact of the Tracy fire, and ongoing quality-related investments and uncertainty. Management nevertheless maintained its long-term growth outlook and described the underlying commercial momentum as strong.
View all MDLN earnings summariesMDLN Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 3 | 4 |
| Technical Analysis | 3 | 3 | 4 |
| Moving Averages | 12 | 0 | 0 |
